Canine Cushing's Forums  

Go Back   Canine Cushing's Forums > Important Information and Resources


Closed Thread
Thread Tools Search this Thread Display Modes
Old 09-09-2007, 09:55 AM
CairnTerrierMom's Avatar
CairnTerrierMom CairnTerrierMom is offline
Join Date: Sep 2005
Location: Chicago, IL
Posts: 997
Images: 5
Default Medical Management of Pituitary-Dependent Hyperadrenocorticism

Medical Management of Pituitary-Dependent
Hyperadrenocorticism: Mitotane versus Trilostane
Nyssa J. Reine, DVM, ACVIM (Internal Medicine)

Pituitary-dependent hyperadrenocorticism is a common endocrine disorder in dogs in the United States. Once a diagnosis is established, a decision must be made whether or not to pursue treatment, and if so, which medication to use. Historically, mitotane (Lysodren, o,p’-DDD, Bristol-Myers Squibb, New York) has been the most commonly used treatment for medical management. Its use is complicated and comes with many potential side effects, making many practitioners wary of its use. Recently, trilostane has been proven to be an effective treatment of pituitary-dependent hyperadrenocorticism and is approved for use in other countries. Treatment with trilostane is somewhat simpler and the incidence of side effects seems to be less when compared with mitotane therapy. Either treatment can be a safe and effective method of treatment for pituitary-dependent hyperadrenocorticism when the practitioner and client are well educated regarding their use and an appropriate monitoring protocol is used.
Attached Files
File Type: pdf medical_management_reine.pdf (294.9 KB, 154 views)
Closed Thread

Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is Off
HTML code is Off

All times are GMT -5. The time now is 09:28 AM.

Powered by vBulletin® Version 3.7.3
Copyright ©2000 - 2020, Jelsoft Enterprises Ltd.